α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice
Abstract Type 2 diabetes (T2D), alike Parkinson’s disease (PD), belongs to the group of protein misfolding diseases (PMDs), which share aggregation of misfolded proteins as a hallmark. Although the major aggregating peptide in β-cells of T2D patients is Islet Amyloid Polypeptide (IAPP), alpha-synucl...
Guardado en:
Autores principales: | Marija Mucibabic, Pär Steneberg, Emmelie Lidh, Jurate Straseviciene, Agnieszka Ziolkowska, Ulf Dahl, Emma Lindahl, Helena Edlund |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c38137531696423c9b543012d50e5640 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity
por: Emily H. Pilkington, et al.
Publicado: (2017) -
Structural insights from lipid-bilayer nanodiscs link α-Synuclein membrane-binding modes to amyloid fibril formation
por: Thibault Viennet, et al.
Publicado: (2018) -
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity
por: Zand Z, et al.
Publicado: (2019) -
Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration
por: Mantas Ziaunys, et al.
Publicado: (2021) -
Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils
por: Andrius Sakalauskas, et al.
Publicado: (2020)